Salix Pharmaceuticals Company Description
Salix Pharmaceuticals is a finishing school for tummy drugs. Focusing on drugs for gastrointestinal diseases, the company shops for drug products that are nearing commercial viability. It then takes them through the final development stages and brings them to market. The company's products already on the market include Colazal (for ulcerative colitis), Azasan (immune system suppressant), Proctocort (hydrocortisone suppositories and cream for hemorrhoids), and Xifaxan (an antibiotic to prevent travelers' diarrhea). Its string of drug candidates awaiting FDA approval include bowel purgatives and other treatments for ulcerative colitis. Salix' sales and marketing team primarily targets US gastroenterologists.
View the Comprehensive Company Description for Salix Pharmaceuticals
The Company Description provides a historical perspective of Salix Pharmaceuticals's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Salix Pharmaceuticals's evolution in the marketplace.
